供者近期感染SARS-CoV-2与接受异基因造血干细胞移植受者急性移植物抗宿主病发生率升高相关
供者轻度感染早期恢复组急性GVHD II-IV度和III-IV度发生率高于无感染组,晚期恢复组与无感染组相似;多因素分析显示早期恢复组与II-IV度和III-IV度急性GVHD相关,但对生存无显著影响。
要点
- 供者轻度SARS-CoV-2感染早期恢复组急性GVHD II-IV度发生率41.5%,高于无感染组28.1%(p=0.014)。
- 早期恢复组急性GVHD III-IV度发生率22.2%,高于无感染组9.6%(p=0.004)。
- 晚期恢复组急性GVHD风险与无感染组相似(p>0.5)。
核心结论
- 初步证明供者处于轻度SARS-CoV-2感染活动期或早期恢复状态与亲属供者移植后急性GVHD发生率升高相关。
研究设计与样本
- 回顾性分析异基因造血干细胞移植,供者轻度SARS-CoV-2感染或早期恢复阶段为1组(n=65),晚期恢复阶段为2组(n=120),无既往SARS-CoV-2感染供者为0组(n=194)。
主要发现
- 不同供者SARS-CoV-2感染状态的移植原发植入和生存率相当。
- 1组急性GVHD II-IV度发生率41.5%,高于0组28.1%(p=0.014),与2组30.6%比较p=0.067。
- 1组急性GVHD III-IV度发生率22.2%,高于0组9.6%(p=0.004),与2组12.2%比较p=0.049。
- 2组急性GVHD风险与0组相似(p>0.5)。
- 多因素分析显示1组与II-IV度急性GVHD相关(HR 2.307,p=0.010),与III-IV度急性GVHD相关(HR 2.962,p=0.001),对生存未发现显著危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The global pandemic has resulted in the common occurrence of SARS-CoV-2 infection in the population. In the post-pandemic era, it is imperative to understand the influence of donor SARS-CoV-2 infection on outcomes after allogeneic haematopoietic stem cell transplantation (allo-HSCT). We retrospectively analysed allo-HSCTs from donors with mild SARS-CoV-2 infection or early recovery stage (ERS) (group 1, n = 65) and late recovery stage (group 2, n = 120). Additionally, we included allo-HSCT from donors without prior SARS-CoV-2 infection as group 0 (n = 194). Transplants from donors with different SARS-CoV-2 infection status had comparable primary engraftment and survival rates. However, group 1 had higher incidences of acute graft-versus-host disease (aGvHD), grade II-IV (41.5% vs. 28.1% in group 0 [p = 0.014] and 30.6% in group 2 [p = 0.067]) and grade III-IV (22.2% vs. 9.6% [p = 0.004] in group 0 and 12.2% in group 2 [p = 0.049]). Conversely, the risk of aGvHD in group 2 was similar to that in group 0 (p > 0.5). Multivariable analysis identified group 1 associated with grade II-IV (hazard ratio [HR] 2.307, p = 0.010) and grade III-IV (HR 2.962, p = 0.001) aGvHD, which yielded no significant risk factors for survival. In conclusion, we preliminarily demonstrated donors in the active infection state or ERS of mild SARS-CoV-2 infection were associated with higher incidences of aGvHD in transplants from related donors.
引用
- Lin F, Xu L, Han T, et al. Recent infection with SARS-CoV-2 in donors was associated with a higher incidence of acute graft-versus-host disease in recipients undergoing allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2024. PMID: 38924065. doi:10.1111/bjh.19594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。